Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma

Mario Sznol, Jeffrey W. Clark, John W. Smith, Ronald G. Steis, Walter J. Urba, Lawrence V. Rubinstein, Louis A. Vandermolen, John Janik, William H. Sharfman, Robert G. Fenton, Stephen P. Creekmore, Peter Kremers, Kevin Conlon, Jean Hersey, Joy Beveridge, Dan L. Longo

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences